Portfolio news 0

Diffblue Ltd

Diffblue Secures $6.3 Million in New Funding Amidst 3x Growth Period

Oxa

Oxa Unveils Autonomous Ford E-Transit Van and Minibus

Kynos Therapeutics Ltd

Dr. Falk Pharma acquires Kynos Therapeutics, adding acute pancreatitis as a therapeutic focus and further strengthening its development portfolio

Alimetry Limited

Alimetry raises US$18m for next phase of growth

Akamis Bio

Akamis Bio Announces Publication Detailing Initial Proof of Mechanism for NG-350A, an IV-Dosed Tumor Gene Therapy Delivering a CD40 Agonist Payload

Quantum Dice

Quantum Dice and SCI Semiconductor announce partnership to bring quantum-backed cryptography to advanced security systems

Lumai

Lumai Wins ‘Best Overall Technology Award’ at Open Compute Project Foundation Symposium

Bramble Energy Ltd

Bramble Energy announces latest achievement in power density

Storm Therapeutics

STORM Therapeutics to Present Phase 1 Data on its First-in-Class Lead Product STC-15 at EORTC-NCI-AACR Symposium

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies plc - Notification of intention to transfer listing category